Design of patient access schemes in the UK Szymon JarosławskiMondher Toumi Short Communication 06 August 2012 Pages: 209 - 215
Cost-efficacy analysis of the MONET trial using UK antiretroviral drug prices Brian GazzardAndrew HillAnne Anceau Short Communication 06 August 2012 Pages: 217 - 223
Ordering errors, objections and invariance in utility survey responses Eve WittenbergLisa A. Prosser Practical Application 06 August 2012 Pages: 225 - 241
The use of decision-analytic models in Parkinson’s disease James ShearerColin GreenJohn P. Zajicek Review Article 06 August 2012 Pages: 243 - 258
Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis Dirk MuellerAfschin Gandjour Original Research Article 06 August 2012 Pages: 259 - 273
Drugs for rare diseases: Influence of orphan designation status on price Eline PicavetMarc DoomsSteven Simoens Research Letter 06 August 2012 Pages: 275 - 279